Delivery Order SPE2DB22D3010-SPE2DB25FP2XA
Award Date
7/7/25
Potential Completion Date
7/8/25
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product, with a ceiling value of $12,941.28 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, with a ceiling value of $1,726.44 and a period of performance through January 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DALIRESP 500 MCG TABLETS (30S), a medication, with a ceiling value of $8,740.66 and a period of performance through March 14, 2023. The contract is a firm fixed price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DALIRESP 500 MCG TABLET 90S. The contract has a firm fixed price of $5,458.80 and a completion date of May 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of DALIRESP 500 MCG TABLET 30S. The contract has a ceiling value of $33,557.38 and runs through February 4, 2025. The contract is a Firm Fixed Price type and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DALIRESP 500 MCG TABLET 90S. The contract has a firm-fixed price of $25,523.62 and a period of performance through July 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 90S, a prescription medication, with a firm fixed price of $1,985.05 and a completion date of July 14, 2025. The contract is not set aside and was awarded on July 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,476.34, is for the delivery of DALIRESP 500 MCG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 3, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,989.26 and a period of performance through June 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90 tablet bottles of the medication DALIRESP 500 MCG, with a ceiling value of $5,015.42. The contract is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization and a critical supplier of...